BAC
Bank of America Corporation
BAC has the edge over BNY overall, supported by stronger valuation and stronger modeled upside.
BNY
Bank of New York Mellon Corp
BNY trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
BNY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BNY's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BNY.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over BNY in the historical PE scenario, which offers more potential upside but is not a forecast.
BNY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 10x | $94.16 | -38% |
| Fair | 14x | $126 | -18% |
| Expensive | 17x | $151 | -1.1% |
| Current | 17x | $153 | — |
Historical ranges are pointers, not guarantees.
BNY's PE is in its expensive range at 17x.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for BAC, with profitability improving.
BNY Forward outlook
There aren't enough analyst estimates for BNY to show an outlook.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
BNY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.04 | +31% |
| Q2 2026 | $8.58 | +31% |
| Q1 2026 | $8.06 | +31% |
| Q4 2025 | $7.40 | +28% |
| Q3 2025 | $6.92 | +54% |
| Q2 2025 | $6.54 | +55% |
| Q1 2025 | $6.13 | +53% |
| Q4 2024 | $5.80 | +50% |
BNY has the edge over BAC on earnings, with stronger typical year-over-year growth.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over BNY on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC's operating margin was 30% last quarter, down 3.7 points from the same quarter a year ago.
BNY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.7B | +12% |
| Q2 2026 | $5.7B | +13% |
| Q1 2026 | $5.4B | +13% |
| Q4 2025 | $5.2B | +6.8% |
| Q3 2025 | $5.1B | +9.3% |
| Q2 2025 | $5B | +9.4% |
| Q1 2025 | $4.8B | +5.9% |
| Q4 2024 | $4.8B | +12% |
BNY's revenue has grown year over year for 15 quarters in a row: $5.7B last quarter, up 12% from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
BNY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.1B | +$5.6B |
| Q2 2026 | $2B | +7.5% |
| Q1 2026 | -$3.6B | -4046% |
| Q4 2025 | $4.7B | +318% |
| Q3 2025 | -$1.5B | -$815M |
| Q2 2025 | $1.8B | +5.2% |
| Q1 2025 | $92M | +$3.1B |
| Q4 2024 | $1.1B | +$3.5B |
BNY has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over BNY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
BNY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -5.3M shares |
| 1 year | -3.6% | -25.9M shares |
| 3 years | -12% | -94.9M shares |
| 5 years | -19% | -162M shares |
| Available history | -27% | -256M shares |
BNY has 687M diluted shares, down 3.6% from a year ago, with $4.1B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $937M |
| Q2 2026 | $1.1B |
| Q1 2026 | $983M |
| Q4 2025 | $1B |
| Q3 2025 | $849M |
| Q2 2025 | $895M |
| Q1 2025 | $746M |
| Q4 2024 | $750M |
BNY spent $4.1B buying back its own shares over the past year, up 26% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
BNY Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
BNY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.9 | Neutral |
| Stochastic | 45.8 | Neutral |
BNY's weekly RSI is 58 (neutral) and its Stochastic is 46 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over BNY on valuation relative to its sector.
BNY PE vs Financial Services Sector
| Metric | BNY | Sector median | Relative |
|---|---|---|---|
| PE | 17x | 13x | 30% above |
| PE % | 85 | 63 | 22 pts above |
BNY is trading at 17x earnings, a 30% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
BNY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $146.8 | 4.1% above |
| 20 week MA | $153.4 | 0.4% below |
| 50 week MA | $136.8 | 12% above |
| 100 week MA | $114.9 | 33% above |
| 200 week MA | $84.7 | 80% above |
BNY has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
BNY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $50.3 | $41.0 | -18% |
| 2021 | $41.0 | $58.1 | +42% |
| 2022 | $58.1 | $44.7 | -23% |
| 2023 | $44.7 | $52.1 | +17% |
| 2024 | $52.1 | $77.6 | +49% |
| 2025 | $77.6 | $117.5 | +51% |
| 2026 YTD | $117.5 | $152.8 | +30% |
BNY has the edge over BAC on returns for 2026, with the stronger performance.